274 related articles for article (PubMed ID: 2118235)
1. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.
Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235
[TBL] [Abstract][Full Text] [Related]
2. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
[TBL] [Abstract][Full Text] [Related]
3. Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia.
Gerbershagen MU; Wappler F; Fiege M; Kolodzie K; Weisshorn R; Szafarczyk W; Kudlik C; Schulte Am Esch J
Br J Anaesth; 2003 Aug; 91(2):281-4. PubMed ID: 12878630
[TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT2 receptor antagonist ritanserin on halothane-induced increase of inositol phosphates in porcine malignant hyperthermia.
Richter A; Scholz J; Löscher W; Tonner PH; Wappler F
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):593-7. PubMed ID: 8938657
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
[TBL] [Abstract][Full Text] [Related]
7. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors.
Alhaider AA; Hamon M; Wilcox GL
Eur J Pharmacol; 1993 Nov; 249(2):151-60. PubMed ID: 7507056
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.
Jiang XL; Shen HW; Yu AM
Neuropharmacology; 2015 Feb; 89():342-51. PubMed ID: 25446678
[TBL] [Abstract][Full Text] [Related]
10. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J
Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
[TBL] [Abstract][Full Text] [Related]
11. Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
Löscher W; Gerdes C; Richter A
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):365-74. PubMed ID: 7845474
[TBL] [Abstract][Full Text] [Related]
12. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
13. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Darmani NA; Martin BR; Glennon RA
Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
[TBL] [Abstract][Full Text] [Related]
15. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
16. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.
Krebs-Thomson K; Ruiz EM; Masten V; Buell M; Geyer MA
Psychopharmacology (Berl); 2006 Dec; 189(3):319-29. PubMed ID: 17013638
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
18. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
[TBL] [Abstract][Full Text] [Related]
19. Ketanserin and malignant hyperthermia in pigs.
Ording H; Hald A; Sjøntoft E
Acta Anaesthesiol Scand; 1986 Jan; 30(1):7-9. PubMed ID: 2938396
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
